Zaremba Rabourn Amy has filed 12 insider transactions across 1 company since January 2023.
Most recent transaction: a sale of 2816 shares of Opus Genetics, Inc. ($IRD) on March 16, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Opus Genetics, Inc. | $IRD | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | S | Common Stock | 2816 | $5.25 | 190,312.0000 | 70,636,887 | 1.46% | 0.00% |
| Jan. 22, 2026 | Opus Genetics, Inc. | $IRD | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | A | Common Stock | 86500 | $0.00 | 193,128.0000 | 70,636,887 | 81.12% | 0.12% |
| Jan. 18, 2026 | Opus Genetics, Inc. | $IRD | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | F | Common Stock | 3390 | $2.10 | 106,628.0000 | 70,636,887 | 3.08% | 0.00% |
| Jan. 10, 2026 | Opus Genetics, Inc. | $IRD | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | F | Common Stock | 3950 | $1.93 | 110,018.0000 | 70,636,887 | 3.47% | 0.01% |
| March 13, 2025 | Opus Genetics, Inc. | $IRD | Zaremba Rabourn Amy | SVP of Finance | A | Employee Stock Option (right to buy) | 39500 | $0.00 | 39,500.0000 | 26,715,526 | 9999.99% | 0.15% |
| March 13, 2025 | Opus Genetics, Inc. | $IRD | Zaremba Rabourn Amy | SVP of Finance | A | Common Stock | 39500 | $0.00 | 113,968.0000 | 26,715,526 | 53.04% | 0.15% |
| Feb. 4, 2025 | Opus Genetics, Inc. | $IRD | Zaremba Rabourn Amy | SVP of Finance | F | Common Stock | 8190 | $1.14 | 74,468.0000 | 26,715,526 | 9.91% | 0.03% |
| Jan. 18, 2024 | Opus Genetics, Inc. | $IRD | Zaremba Rabourn Amy | SVP of Finance | A | Employee Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 21,589,821 | 9999.99% | 0.28% |
| Jan. 18, 2024 | Opus Genetics, Inc. | $IRD | Zaremba Rabourn Amy | SVP of Finance | A | Common Stock | 40000 | $0.00 | 82,658.0000 | 21,589,821 | 93.77% | 0.19% |
| Jan. 10, 2024 | Opus Genetics, Inc. | $IRD | Zaremba Rabourn Amy | SVP of Finance | F | Common Stock | 3950 | $3.27 | 42,658.0000 | 21,589,821 | 8.47% | 0.02% |
| Jan. 10, 2023 | Opus Genetics, Inc. | $IRD | Zaremba Rabourn Amy | SVP of Finance | A | Common Stock | 46608 | $0.00 | 46,608.0000 | 0 | 9999.99% | 0.00% |
| Jan. 10, 2023 | Opus Genetics, Inc. | $IRD | Zaremba Rabourn Amy | SVP of Finance | A | Employee Stock Option (right to buy) | 69912 | $0.00 | 69,912.0000 | 0 | 9999.99% | 0.00% |